Dexin China Holdings Company Limited
HKEX:2019.HK
0.085 (HKD) • At close July 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2018 Q4 | 2018 Q3 | 2017 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,270.368 | 6,270.368 | 5,984.538 | 5,984.538 | 5,949.492 | 5,949.492 | 5,123.249 | 2,486.781 | 3,254.388 | 3,476.218 |
| Cost of Revenue
| 6,128.684 | 6,128.684 | 5,226.595 | 5,226.595 | 5,496.808 | 5,496.808 | 4,487.051 | 1,220.816 | 2,221.585 | 2,533.978 |
| Gross Profit
| 141.684 | 141.684 | 757.943 | 757.943 | 452.685 | 452.685 | 636.198 | 1,265.965 | 1,032.803 | 942.24 |
| Gross Profit Ratio
| 0.023 | 0.023 | 0.127 | 0.127 | 0.076 | 0.076 | 0.124 | 0.509 | 0.317 | 0.271 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 179.962 | 179.962 | 347.459 | 347.459 | 206.367 | 206.367 | 228.868 | 324.603 | -34.766 | 38.934 |
| Selling & Marketing Expenses
| 263.473 | 263.473 | 159.441 | 159.441 | 225.722 | 225.722 | 118.868 | 122.599 | 82.041 | 90.168 |
| SG&A
| 443.435 | 443.435 | 506.9 | 506.9 | 432.089 | 432.089 | 347.735 | 447.202 | 47.275 | 129.102 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -169.07 | 147.388 | 71.461 |
| Operating Expenses
| 671.754 | 671.754 | 695.676 | 695.676 | 423.708 | 423.708 | 74.515 | 278.132 | 194.663 | 200.563 |
| Operating Income
| -352.904 | -352.904 | 263.788 | 263.788 | 162.476 | 162.476 | 282.784 | 1,411.971 | 896.675 | 845.442 |
| Operating Income Ratio
| -0.056 | -0.056 | 0.044 | 0.044 | 0.027 | 0.027 | 0.055 | 0.568 | 0.276 | 0.243 |
| Total Other Income Expenses Net
| -324.039 | -324.039 | -242.395 | -242.395 | -145.446 | -145.446 | 281.141 | -151.582 | -30.889 | -18.086 |
| Income Before Tax
| -676.942 | -676.942 | 21.393 | 21.393 | 17.031 | 17.031 | 563.924 | 1,260.389 | 865.786 | 827.356 |
| Income Before Tax Ratio
| -0.108 | -0.108 | 0.004 | 0.004 | 0.003 | 0.003 | 0.11 | 0.507 | 0.266 | 0.238 |
| Income Tax Expense
| 120.166 | 120.166 | 204.438 | 204.438 | 388.176 | 388.176 | 112.012 | 400.647 | 347.193 | 221.872 |
| Net Income
| -835.3 | -835.3 | -259.159 | -259.159 | -183.37 | -183.37 | 370.228 | 665.528 | 518.593 | 466.885 |
| Net Income Ratio
| -0.133 | -0.133 | -0.043 | -0.043 | -0.031 | -0.031 | 0.072 | 0.268 | 0.159 | 0.134 |
| EPS
| -0.28 | -0.28 | -0.087 | -0.087 | -0.067 | -0.067 | 0.14 | 0.25 | 0.2 | 0.18 |
| EPS Diluted
| -0.28 | -0.28 | -0.087 | -0.087 | -0.067 | -0.067 | 0.14 | 0.25 | 0.2 | 0.18 |
| EBITDA
| -344.125 | -344.125 | 280.777 | 280.777 | 171.415 | 176.114 | 305.818 | 1,415.75 | 1,014.951 | 928.013 |
| EBITDA Ratio
| -0.055 | -0.055 | 0.047 | 0.047 | 0.029 | 0.03 | 0.06 | 0.569 | 0.312 | 0.267 |